Research output per year
Research output per year
Fingerprint
Dive into the research topics where Giuseppa De Luca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
- 6 Article
-
Radiomic Detection of EGFR Mutations in NSCLC
Rossi, G., Barabino, E., Fedeli, A., Ficarra, G., Coco, S., Russo, A., Adamo, V., Buemi, F., Zullo, L., Dono, M., De Luca, G., Longo, L., Dal Bello, M. G., Tagliamento, M., Alama, A., Cittadini, G., Pronzato, P. & Genova, C., Feb 1 2021, In: Cancer Research. 81, 3, p. 724-731 8 p.Research output: Contribution to journal › Article › peer-review
-
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling
De Luca, G., Cardinali, B., Del Mastro, L., Lastraioli, S., Carli, F., Ferrarini, M., Calin, G. A., Garuti, A., Mazzitelli, C., Zupo, S. & Dono, M., Jun 2020, In: International Journal of Molecular Sciences. 21, 12, p. 1-19 19 p., 4364.Research output: Contribution to journal › Article › peer-review
Open Access -
Performance of the oncomineTM Lung cfDNA assay for liquid biopsy by NGS of NSCLC patients in routine laboratory practice
De Luca, G., Lastraioli, S., Conte, R., Mora, M., Genova, C., Rossi, G., Tagliamento, M., Coco, S., Dal Bello, M. G., Zupo, S. & Dono, M., 2020, In: Appl. Sci.. 10, 8Research output: Contribution to journal › Article › peer-review
-
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
Monti, P., Lionetti, M., De Luca, G., Menichini, P., Recchia, A. G., Matis, S., Colombo, M., Fabris, S., Speciale, A., Barbieri, M., Gentile, M., Zupo, S., Dono, M., Ibatici, A., Neri, A., Ferrarini, M., Fais, F., Fronza, G., Cutrona, G. & Morabito, F., 2020, In: Sci. Rep.. 10, 1Research output: Contribution to journal › Article › peer-review
-
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors
Morabito, F., Gentile, M., Monti, P., Recchia, A. G., Menichini, P., Skafi, M., Atrash, M., De Luca, G., Bossio, S., Al-Janazreh, H., Galimberti, S., Salah, Z., Morabito, L., Mujahed, A., Hindiyeh, M., Dono, M., Fais, F., Cutrona, G., Neri, A., Tripepi, G. & 2 others, , 2020, In: Expert Opin. Invest. Drugs. 29, 8, p. 869-880 12 p.Research output: Contribution to journal › Article › peer-review